Gesa J. Schad | Authors

Quantifying the content of coumarin and cinnamaldehyde in cinnamon products

This article introduces optimization of the two separate standard methods, BS148:2009 and ASTM D5837-15, to offer simultaneous analysis in one assay.

An analytical method for the separation of oligonucleotides of different chain length by IEC using a bio-inert UHPLC system is presented.

A high-speed and simultaneous analysis of common active ingredients used in mouthwashes on a C18 column

Partial coelution of chromatographic peaks is an often-encountered issue in high performance liquid chromatography (HPLC) analysis, despite best efforts in method development and optimization. Even though there are several ways of integration of overlapping signals, accurate quantification of single compounds using conventional photodiode array (PDA) detection is almost impossible without baseline separation. While extensive signal processing is well established in spectroscopic analyses such as infrared (IR) or nuclear magnetic resonance (NMR), it has not yet been commonly adapted to improve chromatographic data evaluation. This article introduces the theory and application of a novel data analysis technique for PDA detection to accurately determine and quantify single compounds, even from overlapping peaks, without the need for mass spectrometry (MS) detection.

Quantification of cannabinoids is essential for the accurate labelling of hemp products, both for quality control and for establishing legality with regards to d9-tetrahydrocannabinol (THC) content. For this article, the cannabinoid content of several cannabidiol (CBD)-rich hemp tea samples was determined and was found to often deviate from the content stated on the packaging. Just like the cannabis flower, hemp tea can be analyzed easily and effectively for its cannabinoid content using high performance liquid chromatography (HPLC). The HPLC–UV assay of choice provided good linearity, low limits of detection (LODs), and high precision of retention time and peak area for the 11 cannabinoids under investigation.